Department of Medicine

Division Chief Hematology and Oncology

Robert de W Marsh, M.D., FACP Professor of Medicine Division of Hematology/Oncology Professor and Chairman of the Shands Hospital Cancer Committee, University of Florida Shands Cancer Center Protocol Review Committee. 1600 SW Archer Road Box 100277 Gainesville, FL  32610-0277 (352) 273-7832/FAX (352) 273-5006

Robert de Wilton Marsh is a Board Certified Internist, Medical Oncologist, and Hematologist with expertise in the treatment of all Gastrointestinal and Genitourinary cancers as well as Cancers of Unknown Primary. He is Chairman of the Shands Hospital Cancer Committee and also of the University of Florida Shands Cancer Center Protocol Review Committee. He is Principle Investigator for the Eastern Co-operative Oncology Group at the University of Florida and has served as head of the Clinical Trials Office and of the Florida Clinical Trials Co-operative. He is the Director of the Hematology/Oncolgy Clinic and the Shands Infusion Center. He is a strong advocate of physical fitness and an avid cyclist.

Training:

Academic Interests:

His main area of expertise and interest is in gastrointestinal and genitourinary cancers. A major focus is the understanding of the inheritance and biology of pancreatic and hepatobiliary tumors, colorectal and rectal cancer, and the development of novel translational therapeutics in these areas. He has additional foci of interest in the development of novel therapeutics for the prevention and treatment of prostate cancer and in the use of new molecular techniques for the identification of unique DNA and RNA signatures in individual tumors.

Clinical Interests:

The prevention, diagnosis, treatment and cure of all malignancies, but especially gastrointestinal and genitourinary tumors, along with cancers of unknown primary. The compassionate care of all patients with cancer.

Representative Publications:

• Vauthey JN, Marsh RW, Davis GL. Treatment of unresectable hepatocellular carcinoma. N Engl J Med 1995 Sep 28;333(13):877.
• Marsh R de W, Chu N-M, Vauthey JN, Mendenhall W, Bewsher C, Copeland EM. Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologocially shaped 5-FU infusion and radiation therapy. Cancer 1996; 78:217-225.
• Parulekar W, Marsh R deW, Bjarnason G. A Phase I/II Study of Chronomodulated infusion of 5FU and Leucovorin together with Radiation Therapy in locally advanced and recurrent Rectal Cancer. Int. J Radiation Oncology Biol. Phys. 58 (5);1487-1495, 2004.
• Marsh R de W, George T. A rational approach to radiation and chemotherapy for pancreatic cancer. American Gastroenterology Reports. 8:2 111-120. April 2006.
• Marsh R de W, Levy D, Rocha Lima C, Mitchell E, Rowland Jr. K, Benson, III. Phase II Trial of Perifosine in Locally Advanced, Unresectable or Metastatic Pancreatic Adenocarcinoma: Eastern Cooperative Oncology Group Study E1202 Am J Clin Oncol. 2007 Feb;30(1):26-31